Canadian Licensed Producer Canopy Growth Corp’s (
TSX: WEED) pharmaceutical business, Spectrum Therapeutics, continues to make headway into Europe after announcing two new deals in the continent. Canopy said its Spectrum Therapeutics business received licences from the UK government to store and distribute cannabis-based medicinal products as well as import those products from its own global cultivation network.
Canopy also said it has won a two-year contract to be the exclusive supplier of medical cannabis in Luxembourg.
For full press release, click
here.